Trump Administration Eliminates NIH Research Institutes Congress Just Voted To Preserve, Resolving Long-Standing Concern That The People's Representatives Still Had A Say In Which Diseases Get Studied
WASHINGTON. The Trump administration confirmed this week that it is proceeding to consolidate the National Institutes of Health from 27 research institutes down to eight, eliminating outright the bodies devoted to minority health, nursing, global health, and integrative medicine, roughly four months after Congress wrote all 27 of them into law and declined to authorize a single one of the closures.
The dismantling has advanced without a vote. The Consolidated Appropriations Act signed in February funded the full slate of institutes and centers at $47.5 billion, an explicit instruction that the agency remain intact. Administration officials have treated the instruction as a starting point for negotiation with themselves, achieving through hiring freezes, communications pauses, office closures, and the quiet non-renewal of grants what the legislative branch had specifically refused to approve.
"Congress told us how much to spend, not how to feel about it," said one senior official, who requested anonymity to describe a restructuring the official characterized as both already complete and not technically happening. The official noted that the agency had issued roughly two-thirds fewer grant awards in the opening months of 2026 than in the same period a year earlier, a figure presented as evidence of newfound efficiency.
The four institutes marked for elimination conduct the federal government's research into why Black mothers die in childbirth at higher rates, how nurses keep patients alive after they leave the hospital, and which diseases crossing oceans might arrive next. Under the new structure, those questions will be folded into other institutes or, in the administration's preferred formulation, resolved.
The campaign began the day after the inauguration, when political appointees imposed a pause on NIH communications and instructed scientists not to attend the public meetings where grant decisions are reviewed, in several cases halting the meetings minutes before they were scheduled to begin. Researchers describe a system being disassembled faster than anyone outside the building can document, which sources within the administration confirmed was the point.
At press time, officials had announced that the consolidated agency would retain just enough staff to inform the public that American biomedical research remained the envy of the world.